HFpEF and HFrEF drug, device, and outcomes trials covered weekly in The Rhythm's cardiology briefing.
Electrophysiology
Issue 24 | Week of 14 September 2026 Cardiology Intelligence Briefing: diagnosis outpaces treatment This was a week in which cardiology got sharper at telling patients apart, while two plausible treatments failed to deliver.34 A large European cohort showed that combining cardiac imaging with genetic testing separates high and low
Heart Failure
Issue 21 | Week of 24 August 2026 No major cardiology congress fell this week. The European Society of Cardiology (ESC) Congress 2026 begins next week in Munich, running 28 to 31 August. Cardiology Intelligence Briefing: how far the evidence travels Once a therapy, test, or clinical pathway has been shown
Hypertension
Issue 19 | Week of 10 August 2026 No major cardiology congress fell this week. The strongest evidence came directly from European Heart Journal's advance articles, spanning pregnancy history, pharmacogenomics, diet, real-world heart failure practice, and cardio-oncology. Cardiology Intelligence Briefing: the case for granularity This week'
Heart Failure
Issue 18 | Week of 3 August 2026 No major general cardiology congress fell in this window. The week's evidence arrived through routine journal publication across JAMA, JAMA Internal Medicine, JAMA Cardiology and Circulation. Cardiology Intelligence Briefing: the value already sitting in the system This week's five
Atrial Fibrillation
Issue 17 | Week of 27 July 2026 No major cardiology congress fell this week. The most consequential evidence arrived through journal publication, and the five papers split cleanly into three states: established treatment hierarchies being reconsidered, proven interventions that still are not reaching enough patients, and one promising tool not
Heart Failure
Issue 15 | Week of 13 July 2026 No major cardiology congress fell this week. The evidence arrived through journal publication, and it was thinner than most weeks this year, but a single thread ran through what did appear: cardiology repeatedly asking whether a default setting, a default treatment, or a
Hypertension
Issue 14 | Week of 6 July 2026 No major cardiology congress fell this week. Instead the evidence arrived through journals and a co-published multisociety consensus document, and it clustered around a single question: not whether a treatment or a definition is correct in principle, but whether it is precise
Coronary Intervention
Issue 11 | Week of 15 June 2026 No major cardiology congress fell this week. The most consequential evidence arrived through journal publication, and a single thread ran through it: a treatment can be mechanistically sound, biologically attractive, or statistically associated with benefit, and still fail when it is tested properly.
Heart Failure
Issue 9 | Week of 1 June 2026 No major general cardiology congress fell in this window, and the week's most-discussed evidence arrived mainly through journal publication, including two early-phase platform studies in the New England Journal of Medicine. Cardiology Intelligence Briefing: the distance between promise and
Heart Failure
Issue 7 | Week of 18 May 2026 Heart Failure 2026 closed in Barcelona on 12 May. The week that followed is lighter on the congress calendar but heavier on the questions large trials are not designed to answer. Cardiology Intelligence Briefing: between the landmarks Landmark cardiovascular trials earn their authority
Heart Failure
Issue 6 | Week of 11 May 2026 Heart Failure 2026 is taking place in Barcelona from 9 to 12 May, dominating this week's evidence with four major publications across Nature Medicine and JAMA. Cardiology Intelligence Briefing: old drugs, new evidence Heart Failure 2026 week produced an unexpected protagonist: